S1PR5 and myeloid sarcoma: Studies in experimental MS, especially in the EAE model, have attempted to define the molecular mechanisms underlying these effects, highlighting the involvement of S1P1 or S1P5 specifically expressed on astroglia and oligodendrocytes, respectively [23,24,25,26,27].